Company: HRTX
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0000950170-25-063971
Chunk: 2

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-05-06
Form: 10-Q
Item: Item 1
Chunk 2
---
HERON THERAPEUTICS, INC.

Condensed Consolidated Balance Sheets

(In thousands)

     March 31,2025

     December 31,2024

     (Unaudited)

     (See Note 2)

     ASSETS

     Current assets:

     Cash and cash equivalents
      
     $
     19,269

     $
     25,802

     Short-term investments

     31,410

     33,481

     Accounts receivable, net

     78,736

     78,881

     Inventory, net

     56,932

     53,160

     Prepaid expenses and other current assets

     26,494

     17,690

     Total current assets

     212,841

     209,014

     Property and equipment, net

     14,537

     14,863

     Right-of-use lease assets

     2,091

     2,787

     Other assets

     6,283

     6,483

     Total assets
      
     $
     235,752

     $
     233,147

     LIABILITIES AND STOCKHOLDERS’ DEFICIT

     Current liabilities:

     Accounts payable
      
     $
     12,333

     $
     11,709

     Accrued clinical and manufacturing liabilities

     20,060

     25,402

     Accrued payroll and employee liabilities

     6,451

     9,554

     Other accrued liabilities

     47,423

     41,755

     Current lease liabilities

     2,290

     3,037

     Total current liabilities

     88,557

     91,457

     Non-current notes payable, net

     25,213

     25,026

     Non-current convertible notes payable, net

     149,753

     149,700

     Other non-current liabilities

     682

     615

     Total liabilities

     264,205

     266,798

     Stockholders’ deficit:

     Common stock

     1,524

     1,521

     Additional paid-in capital

     1,886,981

     1,884,409

     Accumulated other comprehensive income

     1

     13